Outlook Therapeutics (OTLK) Total Non-Current Liabilities (2015 - 2026)
Outlook Therapeutics' Total Non-Current Liabilities was $28.82 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 44.7% from $52.13 million a year earlier and down 42.6% from the prior quarter.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Total Non-Current Liabilities at Outlook Therapeutics came in at $46 million, up 7.5% from FY2024.
- Total Non-Current Liabilities shows a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- In earlier fiscal years, Total Non-Current Liabilities was $42.8 million in FY2024 (-8.4%), $46.73 million in FY2023 (+136.8%), $19.73 million in FY2022 (+11.6%) and $17.68 million in FY2021 (+5.0%).
- The fiscal Q3 2026 figure marks the lowest quarterly Total Non-Current Liabilities since fiscal Q4 2022.
- Compared with a year earlier, Total Non-Current Liabilities was higher in five of the last eight quarters, with an average decline of 2.9%.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was fiscal Q3 2023 (growth of 170.8%); the worst was fiscal Q3 2026 (a decline of 44.7%).
- Per Business Quant data, OTLK's Total Non-Current Liabilities in the three fiscal quarters before Q3 2026 was $50.16 million (Q2 2026), $49.23 million (Q1 2026) and $46 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | 28.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.82 Mn |
| Mar 31, 2026 | 50.16 Mn |
| Dec 31, 2025 | 49.23 Mn |
| Sep 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 52.13 Mn |
| Mar 31, 2025 | 46.09 Mn |
| Dec 31, 2024 | 48.47 Mn |
| Sep 30, 2024 | 42.80 Mn |
| Jun 30, 2024 | 42.81 Mn |
| Mar 31, 2024 | 54.08 Mn |
| Dec 31, 2023 | 45.97 Mn |
| Sep 30, 2023 | 46.73 Mn |
| Jun 30, 2023 | 49.93 Mn |
| Mar 31, 2023 | 43.53 Mn |
| Dec 31, 2022 | 46.90 Mn |
| Sep 30, 2022 | 19.73 Mn |
| Jun 30, 2022 | 18.44 Mn |
| Mar 31, 2022 | 31.43 Mn |
| Dec 31, 2021 | 29.58 Mn |
| Sep 30, 2021 | 17.68 Mn |
API Access
Outlook Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();